RoActemra - supply shortage
Shortage resolved
tocilizumab
ShortageHuman
Swedish is available via eTranslation, the European Commission's machine translation service.
Translate to Swedish | Important information about machine translation
Shortage information
The shortage affecting RoActemra has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- RoActemra
- Supply shortage status
- Shortage resolved
- International non-proprietary name (INN) or common name
- tocilizumab
- Therapeutic area (MESH)
- Arthritis, Rheumatoid
- Arthritis, Juvenile Rheumatoid
- Cytokine Release Syndrome
- Giant Cell Arteritis
- COVID-19 virus infection
- Pharmaceutical forms affected
- Pre-filled syringe
- Pre-filled pen
- Solution for subcutaneous injection
- Concentrate for solution for infusion
- Strengths affected
- 162 mg (syringe, pen)
- 20 mg/ml (concentrate)
- Availability of alternatives
- Yes
Key dates
- First published
- Last updated